Discontinuation of BRAF/MEK-Directed Targeted Therapy after Complete Remission of Metastatic Melanoma-A Retrospective Multicenter ADOReg Study

DSpace Repository

Discontinuation of BRAF/MEK-Directed Targeted Therapy after Complete Remission of Metastatic Melanoma-A Retrospective Multicenter ADOReg Study

Author: Stege, Henner; Haist, Maximilian; Schultheis, Michael; Fleischer, Maria Isabel; Mohr, Peter; Meier, Friedegund; Schadendorf, Dirk; Ugurel, Selma; Livingstone, Elisabeth; Zimmer, Lisa; Herbst, Rudolf; Pfoehler, Claudia; Kaehler, Katharina; Weichenthal, Michael; Terheyden, Patrick; Nashan, Dorothee; Debus, Dirk; Kaatz, Martin; Ziller, Fabian; Haferkamp, Sebastian; Forschner, Andrea; Leiter, Ulrike; Kreuter, Alexander; Ulrich, Jens; Kleemann, Johannes; Bradfisch, Fabienne; Grabbe, Stephan; Loquai, Carmen
Tübinger Autor(en):
Forschner, Andrea Lydia
Leiter-Stöppke, Ulrike
Published in: Cancers (2021), Bd. 13 (10), Article 2312
Verlagsangabe: Mdpi
Language: English
Full text: http://dx.doi.org/10.3390/cancers13102312
ISSN: 2072-6694
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)